What are the causes of ischemic hepatitis?

Causes of Ischemic Hepatitis

Ischemic hepatitis results primarily from hepatic hypoperfusion due to systemic hypoxic or hypotensive states, most commonly occurring in patients with underlying cardiac dysfunction, circulatory shock, or severe heart failure. 1, 2, 1

Primary Etiologic Categories

Cardiovascular Causes (Most Common)

The predominant mechanism involves cardiac dysfunction leading to hepatic hypoperfusion. Approximately 78% of ischemic hepatitis cases have a predisposing acute cardiac event 3:

• Severe heart failure - the leading cause, often with congestive features 2, 4, 5
• Cardiac arrest 2
• Acute myocardial infarction
• Arrhythmias (particularly atrial fibrillation causing hemodynamic compromise)
• Cardiogenic shock

Circulatory Shock States

Septic shock accounts for approximately 23% of ischemic hepatitis cases 3:

• Septic shock - second most common cause 2, 6
• Hypovolemic shock from significant blood loss or severe dehydration 2
• Distributive shock from other causes

Respiratory Failure

• Severe hypoxemia from respiratory failure contributing to hepatic hypoxia 2, 4, 6

Vascular Causes

Selective hepatic hypoperfusion from vascular occlusion 1:

• Hepatic artery occlusion or thrombosis
• Portal vein thrombosis (Budd-Chiari syndrome) 2
• Hepatic vein thrombosis

Drug-Induced Hypoperfusion

• Cocaine or methamphetamine causing vasoconstriction and hypoperfusion 2
• Long-acting niacin 2

Pathophysiologic Mechanism: The "Two-Hit" Model

Ischemic hepatitis typically requires a "two-hit" mechanism 5:

1. First hit: Pre-existing hepatic congestion or underlying cardiac disease that compromises baseline hepatic perfusion
2. Second hit: Acute systemic hypoperfusion or hypotensive episode superimposed on the vulnerable liver

Critical Clinical Caveat

Only 53% of ischemic hepatitis patients have documented hypotension 3. This means nearly half of cases occur without recorded hypotensive episodes, making recognition challenging. The condition can develop from:

• Relative hypoperfusion in the setting of chronic cardiac dysfunction
• Hepatic venous congestion from right heart failure reducing hepatic blood flow
• Combination of mild hypotension with pre-existing hepatic congestion

Associated Comorbidities

Patients developing ischemic hepatitis typically have multiple predisposing conditions:

• Pre-existing cardiovascular disease (most common risk factor) 5
• Chronic heart failure with hepatic congestion 5
• Cirrhosis (impairs hepatic microcirculation and ischemia tolerance) 7
• Hepatic steatosis (decreases resistance to ischemia-reperfusion injury) 7
• Renal dysfunction (often concurrent)

Clinical Recognition

Ischemic hepatitis represents the most common cause of marked transaminase elevation >1000 IU/L, accounting for 51% of such cases 8. The typical biochemical pattern shows:

• AST and ALT levels typically >1000 IU/L (mean peak ~2400 IU/L and ~1900 IU/L respectively) 3
• Rapid rise and fall of transaminases (within 24-72 hours after correction of hemodynamics)
• LDH elevation
• Often accompanied by acute kidney injury

Epidemiology

Ischemic hepatitis occurs in approximately 2 per 1000 hospital admissions, 2.5 per 100 ICU admissions, and represents 4 in 10 cases of aminotransferase elevation >10 times upper limit of normal 3.

Prognostic Implications

Mortality in ischemic hepatitis is significantly higher than other causes of marked transaminase elevation, with an odds ratio of 21 8. Overall survival to discharge is only 51% 3, with mortality primarily determined by the underlying hemodynamic disturbance rather than the hepatic injury itself 4, 5.